Differences in demographics and behaviors across two web-based survey platforms: Observations from a study of risk perceptions of heated tobacco products (HTPs)

Sharma, Akshika; Fix, Brian V.; Hyland, Andrew; Quisenberry, Amanda J.; Bansal-Travers, Maansi; O’Connor, Richard J.

doi:10.1016/j.pmedr.2023.102194

Cited by 5 publications

(1 citation statement)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Amazon Mechanical Turk, popularly known as Mturk, is a large crowdsourcing platform that has been widely used for research. Participants on Mturk self-select themselves for participation in a study based on its eligibility criteria and monetary rewards, whereas Prime Panels are participant pools drawn from commercial panels based on specific eligibility criteria ( 21 ). After providing informed consent, participants were asked about their demographics, current tobacco product use, and their awareness of, or experience with HTPs.…”

Section: Methodsmentioning

confidence: 99%

Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey

Sharma,

Fix,

Hyland

et al. 2024

Front. Public Health

Self Cite

View full text Add to dashboard Cite

IntroductionIQOS was authorized to be marketed as a reduced exposure product by the Food and Drug Administration in October 2020 during the global COVID-19 pandemic. Those who smoke may be more sensitive to reduced exposure marketing claims and may have an increased inclination toward IQOS use. We evaluated the likelihood of trying and purchasing IQOS as a function of exposure to ads, product appeal, and COVID-19 risk perceptions using the original IQOS ads with reduced exposure marketing.MethodAn online cross-sectional survey recruited 604 US adults (18–45 years), both who smoke and do not smoke. Participants saw one of the six randomly assigned IQOS ads with or without reduced exposure claims, and they answered questions about product appeal and likelihood to try and purchase IQOS. Generalized linear models were used to examine associations.ResultsA per unit increase in product appeal was associated with a greater likelihood of purchasing (B = 0.17, 95% CI: 0.15–0.18) and trying IQOS (B = 0.16, 95% CI = 0.14–0.18). Current smokers and former e-cigarette users reported greater intentions to try IQOS than never-smokers and never e-cigarette users, respectively. Likelihood to purchase IQOS was associated with greater confidence in not contracting COVID-19 (B = 0.11, 95% CI: 0.01–0.21). No significant differences were observed between different ad conditions. Current (B = −0.34, 95% CI = −0.50-(−0.19)) and former (B = −0.92, 95% CI = −0.15-(−0.68)) cigarette smokers who were someday e-cigarette users reported less intentions to purchase IQOS than never e-cigarette users. However, never smokers who were someday (B = 0.58, 95% CI = 0.27–0.89; B = 0.68, 95% CI = 0.39–0.98) and former e-cigarette (B = 0.38, 95% CI = 0.15–0.61) users reported greater intentions to purchase and try IQOS, respectively.DiscussionIQOS may have a higher product appeal, especially for those who currently smoke and those who have lower risk perceptions from COVID-19. Among never smokers, those who currently use or have used e-cigarettes in the past may be more receptive to IQOS marketing. The data are informative for potential trends in the use of IQOS in the future and may have implications for marketing regulations of heated tobacco products (HTPs).

show abstract

Section: Methodsmentioning

confidence: 99%

Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey

Sharma,

Fix,

Hyland

et al. 2024

Front. Public Health

Self Cite

View full text Add to dashboard Cite

show abstract

Rethinking the Dunning-Kruger effect: Negligible influence on a limited segment of the population

Gignac

2024

Intelligence

View full text Add to dashboard Cite

An effective COVID-19 vaccine hesitancy intervention focused on the relative risks of vaccination and infection

Byerley,

Horne,

Gong

et al. 2024

Sci Rep

View full text Add to dashboard Cite

We designed the Relative Risk Tool (RRT) to help people assess the relative risks associated with COVID-19 vaccination and infection. In May 2022 (N = 400) and November 2022 (N = 615), U.S. residents participated in a survey that included questions about the risks of vaccination and infection. In both cohorts, we found an association between relative risk perception and vaccine hesitancy. Participants in the May cohort were randomly assigned an intervention: to see information from the RRT or the Centers for Disease Control and Prevention (CDC). After the intervention, participants answered the same questions about risk perception and vaccination intent again. The RRT was more effective than the CDC at changing risk perception and increasing vaccination intent. In November, the survey structure was the same, but the RRT was the only intervention included, and we confirmed that the RRT was effective at changing opinions in this new sample. Importantly, the RRT provided accurate information about the risks of serious adverse outcomes to vaccination and still increased vaccination intent. Our work suggests that the RRT helps people assess relative risk, which can in turn help empower them to make informed decisions and ultimately reduce vaccine hesitancy.

show abstract

Differences in demographics and behaviors across two web-based survey platforms: Observations from a study of risk perceptions of heated tobacco products (HTPs)

Cited by 5 publications

References 37 publications

Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey

Exposure to IQOS ads and reduced exposure claims, and association with perceived risk from COVID-19 on IQOS purchase and use intentions: results from a web-based survey

Rethinking the Dunning-Kruger effect: Negligible influence on a limited segment of the population

An effective COVID-19 vaccine hesitancy intervention focused on the relative risks of vaccination and infection

Contact Info

Product

Resources

About